Search for: "Beecham v. State" Results 181 - 200 of 277
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2010, 7:53 am by Peter S. Lubin and Vincent L. DiTommaso
And it noted that federal courts have previously resolved conflicts between FDA labeling requirements and intellectual property law, including in SmithKline Beecham Consumer Healthcare, L.P. v. [read post]
8 May 2008, 12:22 pm
SmithKline Beecham Corp., 2007 WL 4219157 (D. [read post]
23 Sep 2007, 2:28 pm
SmithKline Beecham Corp., No. 04-01748-DFH-WTL, slip op. [read post]
2 Oct 2008, 12:36 pm
SmithKline Beecham Corp., 671 A.2d 1151, 1155 (Pa. [read post]
19 Sep 2013, 9:53 am by Bexis
  In the consultation report of the neurologist states: “Neurontin is wholly appropriate in this patient. [read post]
10 May 2010, 5:06 pm by INFORRM
  Moreover, it is also now clear that the state has a positive obligation to protect individuals from media intrusion into their private lives. [read post]
27 Sep 2009, 2:30 pm
SmithKline Beecham Corp., 413 F.3d 1318, 1325 (Fed. [read post]
17 Sep 2014, 9:24 am
 The launch of generics pre-patent expiry is a substantial threat to innovators given the dramatic price spiral following the first launch (see commentary in SmithKline Beecham v Apotex). [read post]
27 Aug 2010, 2:41 pm by Bexis
We disagree.In Hoffman, the United States Court of Appeals for the Third Circuit applied Pennsylvania law and concluded that there was sufficient evidence for the jury to find that the manufacturer failed to adequately test its drug to discover potentially harmful side-effects. [read post]
3 Jun 2010, 1:37 pm by Bexis
Smithkline Beecham Corp., 658 N.W.2d 127 (Mich. 2003); Duronio v. [read post]
28 Nov 2006, 4:11 pm
SmithKline Beecham Corp., 413 F.3d 1318, 1325-26 (Fed. [read post]
22 Dec 2011, 11:59 am by Bexis
  All this in a state – Illinois – where the highest court forbids FDCA-based common-law causes of action (see Martin v. [read post]